International Patent: ADENO-ASSOCIATED VECTORS AND PARTICLES TO TREAT TUBEROUS SCLEROSIS COMPLEX CAUSED BY TSC1 GENE MUTATIONS

GENEVA, July 2 -- APERTURA GENE THERAPY filed a patent application (US2025/060780) for “ADENO-ASSOCIATED VECTORS AND PARTICLES TO TREAT TUBEROUS SCLEROSIS COMPLEX CAUSED BY TSC1 GENE MUTATIONS”. With publication no. WO/2026/136962, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/86

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....